Dynamics of the Apo µ-Opioid Receptor in Complex with Gi Protein.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
30 Aug 2023
Historique:
received: 01 07 2023
revised: 24 08 2023
accepted: 25 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Opioid receptors, particularly the µ-opioid receptor (μOR), play a pivotal role in mediating the analgesic and addictive effects of opioid drugs. G protein signaling is an important pathway of μOR function, usually associated with painkilling effects. However, the molecular mechanisms underlying the interaction between the μOR and G protein remain poorly understood. In this study, we employed classical all-atom molecular dynamics simulations to investigate the structural changes occurring with the μOR-G protein complex under two different conditions: with the G protein in the apo form (open) and with the GDP bound G protein (closed, holo form). The receptor was in the apo form and active conformation in both cases, and the simulation time comprised 1µs for each system. In order to assess the effect of the G protein coupling on the receptor activation state, three parameters were monitored: the correlation of the distance between TM3 and TM6 and the RMSD of the NPxxYA motif; the universal activation index (A100); and the χ

Identifiants

pubmed: 37686252
pii: ijms241713430
doi: 10.3390/ijms241713430
pmc: PMC10487971
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Receptors, Opioid 0
GTP-Binding Protein alpha Subunits, Gi-Go EC 3.6.5.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Cell. 1995 Dec 15;83(6):1047-58
pubmed: 8521505
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Pharmacol Exp Ther. 2007 May;321(2):544-52
pubmed: 17267582
Nature. 2012 Mar 21;485(7398):321-6
pubmed: 22437502
Physiol Rev. 2021 Jul 1;101(3):857-906
pubmed: 33331229
Adv Protein Chem. 2003;66:27-85
pubmed: 14631816
Drug Discov Today. 2017 Feb;22(2):249-269
pubmed: 27890821
J Struct Biol. 2013 Jun;182(3):209-18
pubmed: 23523730
J Phys Chem B. 2020 Oct 8;124(40):8784-8793
pubmed: 32926619
J Chem Phys. 2020 Apr 21;152(15):154102
pubmed: 32321259
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171
Nature. 2023 Jan;613(7945):767-774
pubmed: 36450356
J Chem Phys. 2020 Sep 21;153(11):114107
pubmed: 32962386
Acta Pharmacol Sin. 2016 Sep;37(9):1259-72
pubmed: 27498775
Nat Commun. 2022 Feb 8;13(1):731
pubmed: 35136060
Plant Physiol Biochem. 2021 Apr;161:210-221
pubmed: 33639589
J Mol Model. 2019 May 3;25(5):144
pubmed: 31053968
Sci Rep. 2017 Sep 12;7(1):11255
pubmed: 28900175
Drug Discov Today. 2023 Jan;28(1):103419
pubmed: 36309194
Nature. 2015 Aug 20;524(7565):315-21
pubmed: 26245379
Genomics. 2006 Sep;88(3):263-73
pubmed: 16753280
Molecules. 2020 Oct 12;25(20):
pubmed: 33053718
Nat Commun. 2018 Sep 13;9(1):3712
pubmed: 30213947
Methods Cell Biol. 2016;132:359-99
pubmed: 26928552
BMC Res Notes. 2012 Jul 23;5:367
pubmed: 22824207
J Chem Inf Model. 2019 Sep 23;59(9):3938-3945
pubmed: 31448910
QRB Discov. 2021 Aug 05;2:e9
pubmed: 37529677
J Med Chem. 2018 Jan 11;61(1):1-46
pubmed: 28657745
Biomimetics (Basel). 2020 Dec 31;6(1):
pubmed: 33396534
Mol Pharmacol. 2007 Apr;71(4):959-64
pubmed: 17192495
Sci Rep. 2017 Apr 03;8:45761
pubmed: 28368046
Front Cardiovasc Med. 2015 Mar 24;2:14
pubmed: 26664886
Angew Chem Int Ed Engl. 2022 Jun 27;61(26):e202200269
pubmed: 35385593
Nat Chem Biol. 2023 Apr;19(4):423-430
pubmed: 36411392
Angew Chem Int Ed Engl. 2015 Dec 21;54(52):15771-6
pubmed: 26568421
Proc Natl Acad Sci U S A. 2022 May 3;119(18):e2110085119
pubmed: 35452328
Pharmacol Rev. 2013 Sep 27;65(4):1257-317
pubmed: 24076545
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Cell. 2023 Jan 19;186(2):413-427.e17
pubmed: 36638794
Cell. 2022 Nov 10;185(23):4361-4375.e19
pubmed: 36368306
Front Pharmacol. 2019 Feb 19;10:125
pubmed: 30837883
J Mol Biol. 1993 Dec 5;234(3):751-62
pubmed: 8254671
Nucleic Acids Res. 2021 Jan 8;49(D1):D335-D343
pubmed: 33270898
Nucleic Acids Res. 2012 Jan;40(Database issue):D370-6
pubmed: 21890895
Nature. 2018 Jun;558(7711):547-552
pubmed: 29899455
Biochim Biophys Acta Gen Subj. 2021 Mar;1865(3):129838
pubmed: 33373630
Bioinformatics. 2015 Sep 1;31(17):2897-9
pubmed: 25957354
Nat Chem Biol. 2016 Jan;12(1):35-9
pubmed: 26571351

Auteurs

Mira Raya Paula de Lima (MRP)

Biological Chemistry Department, Universidade Regional do Cariri-URCA, Crato 63105-000, CE, Brazil.
Instituto Federal de Educação Ciência e Tecnologia do Ceará-IFCE, Juazeiro do Norte 63040-540, CE, Brazil.

Rubem Francisco Silva Bezerra (RFS)

Biological Chemistry Department, Universidade Regional do Cariri-URCA, Crato 63105-000, CE, Brazil.

David Denis Bento Serafim (DDB)

Biological Chemistry Department, Universidade Regional do Cariri-URCA, Crato 63105-000, CE, Brazil.

Diniz Maciel Sena Junior (DM)

Biological Chemistry Department, Universidade Regional do Cariri-URCA, Crato 63105-000, CE, Brazil.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Lung India Sheep Transcriptome

Classifications MeSH